Trial Profile
Pegfilgrastim Given Same Day as or Day After Carboplatin and Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2016
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Sponsors Amgen
- 19 Oct 2016 New trial record